Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

Fig. 3

a Full-field digital mammography in MLO and CC views and b CESM in MLO and CC views in a 42-year-old woman with pathologically proven invasive duct carcinoma showing a right breast UOQ dense mass lesion with obscured outlines showing intense enhancement at the post-contrast study measuring 2.5 cm in longest diameter. c Follow-up full-field digital mammography in MLO and CC views and CESM in MLO and CC after neoadjuvant chemotherapy showing almost total resolution of the previously seen mass lesion with faint residual enhancing nodule measuring 1.5 cm indicating PR. The patient underwent wide local excision of the right breast lesion. Histopathology assessment revealed CR with no viable tumor cells, free resection margin, and free axillary lymph nodes 0/16

Back to article page